Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>7-Benzyloxy-4-(trifluoromethyl)coumarin is a chemical inhibitor of cytochrome P450 enzymes. It inhibits the catalytic activity of cytochrome P450 enzymes, which are important in drug metabolism and detoxification. This compound has been shown to be a potent inhibitor of CYP3A4 and may have potential as an anti-inflammatory agent. 7-Benzyloxy-4-(trifluoromethyl)coumarin binds reversibly to the heme group of cytochrome P450 enzymes and blocks access by oxygen, preventing the formation of reactive oxygen species that can cause cell damage. 7-Benzyloxy-4-(trifluoromethyl)coumarin has been shown to inhibit the activities of recombinant CYP3A4 enzyme from model organisms such as Saccharomyces cerevisiae, Escherichia coli, and Aspergillus nidul</p>

<p>Versatile small molecule scaffold</p>

<p>Methyl 6-(chloromethyl)pyridine-2-carboxylate is a synthetic ligand that binds to the human serum albumin (HSA) and has been shown to be stable in vitro. The compound has been shown to have high resistance in vivo, which may be due to its metabolism. Methyl 6-(chloromethyl)pyridine-2-carboxylate was found to bind to HSA with a Kd value of 0.5 μM, which is much higher than the binding affinity of other ligands such as methyl 5-(chloromethyl) pyridine-2-carboxylate (Kd=0.035 μM), methyl 2-(chloromethyl)pyrimidine-4-carboxylate (Kd=0.03 μM), and methyl 3-(chloromethyl)piperidine-4-carboxylate (Kd=0.055</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>H-DL-Arg-OH hydrochloride is a proton donor that stabilizes the plasma membrane in cells. It has been shown to inhibit the synthesis of active substances in erythrocytes and to reduce the rate of glucose uptake by these cells. The stability of H-DL-Arg-OH hydrochloride is increased by admixing with chloride salts, which may be due to its ability to form hydrochloride salts. This proton donor has also been shown to have an immune stimulating effect on cell cultures in vitro.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1,3-Di-tert-butyl cyclohexane-1,3-dicarboxylate is a fluorescent probe that senses metal cations. The fluorescence of 1,3-Di-tert-butyl cyclohexane-1,3-dicarboxylate changes in response to changes in the concentration of monovalent and divalent metal cations. This probe can be used to detect the presence of cations in various types of samples such as organic solvents and water. The probe’s fluorescence is proportional to the concentration of metal ions present, with a linear relationship between the change in fluorescence intensity and the change in ion concentration.</p>

<p>4-(4-Methylcyclohexyl)-4-oxobutanoic acid is a drug that enhances the effects of insulin on glucose uptake. It is a potent inhibitor of the ATP-sensitive potassium channels in pancreatic β cells, which leads to an increase in intracellular calcium and insulin secretion. 4-(4-Methylcyclohexyl)-4-oxobutanoic acid has been shown to be effective in treating type 2 diabetes mellitus in min6 cells and neonatal mice. This drug also has a potent effect on pancreatic β cells, leading to an increase in cellular proliferation and hormone release. 4-(4-Methylcyclohexyl)-4-oxobutanoic acid acts as an agonist for the l-type calcium channel, leading to increased extracellular calcium levels and an inhibition of potassium efflux from the cell.</p>

<p>2,4,5-Trichlorophenylboronic acid is a drug substance that is used in the synthesis of imidazole derivatives. It has been shown to induce skin tumor formation when combined with caffeine and midodrine. 2,4,5-Trichlorophenylboronic acid has synergistic effects with other substances such as phorbol esters (e.g., 12-O-tetradecanoylphorbol 13-acetate) or c1-6 alkylating agents (e.g., ethylenimine).</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Cyano-3-hydroxybenzoic acid (4C3HB) is a molecule that contains four methoxy groups and three hydroxyl groups. The molecule has been modified to include carboxy, hydroxy, and methoxy groups. 4C3HB can be synthesized by reacting 3-hydroxybenzoic acid with nitrous acid. This compound is a ligand of the enzyme cytochrome P450. 4C3HB is toxic to cells in vitro and has been shown to inhibit cellular respiration in mitochondria, which may be due to its ability to bind with cytochrome P450. The oral toxicity of this molecule is unknown, but it does not react with DNA or form adducts with proteins. It also does not cause any mutagenicity or carcinogenicity effects in mice.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2,6-Dibromo-4-hydroxypyridine (2,6-DHP) is a low yield chemical compound that is used as an antimalarial agent. It is an epoxide that can be prepared by the Wittig reaction of 2,3-dibromopyridine with ethylene oxide. The population of 2,6-DHP has been shown to have enantiopure properties in the synthesis of pyridines and ring-opening reactions with primary amines. This compound also has low spin and solvates.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(Methylsulfonyl)benzyl alcohol is a ketone that inhibits the catalytic hydrogenation of benzyl groups. It also has been shown to be an antagonist of β-adrenergic receptors. 3-(Methylsulfonyl)benzyl alcohol is used as a catalyst in catalytic bromination and has also been shown to have anti-inflammatory properties.</p>

<p>Versatile small molecule scaffold</p>

<p>4-hydroxy-6-(propan-2-yl)-2H-pyran-2-one is a recombinant molecule made in the laboratory. It is a substrate for recombinant escherichia coli, which are then used to produce large quantities of the molecule. 4-hydroxy-6-(propan-2-yl)-2H-pyran-2-one is also known as an intermediate in the synthesis of other compounds and has been shown to inhibit bacterial growth at high concentrations.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-(1H-Imidazol-1-yl)-3,3-dimethylbutan-2-amine is a chemical compound that belongs to the group of ligands. It has been shown to bind to receptors and ion channels as an agonist or antagonist. This chemical can be used in research as a tool for studying protein interactions and receptor binding.</p>

<p>Versatile small molecule scaffold</p>

<p>tert-Butyl 5-bromopyridine-2-carboxylate is an arylation agent that is used to synthesize a number of different compounds. It is the most potent arylating agent known, with high yields and low toxicity. The benzyl group provides protection against hydrogen chloride and can be removed by hydrolysis. This agent reacts with a variety of aromatic halides in the presence of copper salts to produce a variety of products. Tert-Butyl 5-bromopyridine-2-carboxylate has been shown to have good pharmacokinetic properties, but it's use as an antibiotic has not been studied.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>N-(2-bromo-6-nitrophenyl)acetamide is a bidentate ligand that was synthesized as an acetylated derivative of diazonium salt. It binds to transition metal ions such as copper and nickel, which are important for the catalytic activity of many enzymes. The binding of N-(2-bromo-6-nitrophenyl)acetamide to the active site of these enzymes inhibits the reaction by forming a complex with the substrate, thereby preventing it from reacting with the enzyme. In addition, this ligand has been shown to have strong absorption in the visible range, which is useful for detection of transitions in organic molecules. Nitro groups can be introduced through nitration reactions or by adding nitrobenzene to N-(2-bromo-6-nitrophenyl)acetamide. One advantage of N-(2-bromo-6-nitrophenyl)acetamide over other</p>

<p>Versatile small molecule scaffold</p>

<p>4-Aminopyrimidine-2-carbonitrile is an organic compound that is structurally related to pyrimidine derivatives. It is a drug candidate for the treatment of tuberculosis (TB) and other multidrug resistant bacteria. 4-Aminopyrimidine-2-carbonitrile has been shown to be more potent than formamide and triethyl orthoformate, but less potent than aminopyrazole. The mechanism of action of 4-aminopyrimidine-2-carbonitrile is not well understood, but it may involve an epoxide intermediate that generates reactive oxygen species, which causes necrosis in the bacterial cell. The drug also exhibits some activity against tumour necrosis factor alpha (TNFα).</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>